Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kiuchi, Hiroyuki
RE-GEND, NCT02761070: Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III	Active, not recruiting	3	146	Japan	Temozolomide, Temodar, Temodal, Bevacizumab, Avastin	Kyorin University, Japan Clinical Oncology Group	Glioblastoma, Recurrence, Progression	11/25	11/25
Suzuki-Inoue, Katsue
CLECSTRO, NCT05579405: sCLEC-2 in Stroke Study	Not yet recruiting	N/A	600	Japan		University of Yamanashi	Acute Ischemic Stroke, Transient Ischemic Attack	12/23	12/24
Kinouchi, Hiroyuki
CLECSTRO, NCT05579405: sCLEC-2 in Stroke Study	Not yet recruiting	N/A	600	Japan		University of Yamanashi	Acute Ischemic Stroke, Transient Ischemic Attack	12/23	12/24